Connect with us
The gigantic healthcare market, which is growing steadily, has attracted even more investors since the outbreak of the health crisis. Convinced that investments in health and...
Moderna agreed to sell its coronavirus drug at a "pandemic price" of $32-37 per dose.The biotech company registered losses of $240 million in the first half...
In 2015, Nostoc closed the first round of investment worth $296,000 (€250,000) through the Social Exchange's participatory investment platform. Since then, the company has been growing...
The clinical trial, led by the Catholic University, together with other universities and the Sinovac Biotech laboratory, already has funding from the public sector, the Confederation...
The Swiss pharmaceutical company Roche will supply reagents and consumables and will provide the necessary equipment to carry out analytical serological and biochemical determinations. The BST...
Faes Farma, Pharma Mar, Reig Jofre and Rovi improved their earnings in the first six months of the year. Grifols and Almirall were the two pharma...
Nantes-based biotech company Xenothera is developing Xav-19, a promising antibody for the treatment of COVID-19. Initially announced for the end of June, the start of the...
In March, BioNTech's share price, after rallying to $105, plummeted in two stages to initially $43.66 and then, after an interim recovery to $64.45, to $37....
Almirall cuts its profits as a result of the coronavirus crisis. The Spanish pharmaceutical company justifies this result by the negative impact on the area of...
Managed and owned by Bernard Tannoury, the Benta Pharma group has achieved sales of $77.5 million in 2019 and distributes its products in more than 40...
 |
|
 |  |
 |
|